Publications

Published work

For an updated publication list, please see: weblink

Lange S, Soták M, Hagberg CE, Bagunu G, Vigmo S, Börgeson E. Students at a crossroad: A cross-sectional survey gauging the impact of COVID-19 on medical and biomedical graduates in the United States and Sweden. Biochem Mol Biol Educ. 2023 Jun 24;. doi: 10.1002/bmb.21761. [Epub ahead of print] PubMed PMID: 37354049. Börgeson E, Boucher J, Hagberg CE. Of mice and men: Pinpointing species differences in adipose tissue biology. Front Cell Dev Biol. 2022;10:1003118. doi: 10.3389/fcell.2022.1003118. eCollection 2022. Review. PubMed PMID: 36187476; PubMed Central PMCID: PMC9521710.
Soták M, Rajan MR, Clark M, Harms M, Rani A, Kraft JD, Tandio D, Shen T, Borkowski K, Fiehn O, Newman JW, Quiding-Järbrink M, Biörserud C, Apelgren P, Staalesen T, Hagberg CE, Boucher J, Wallenius V, Lange S, Börgeson E. Lipoxins reduce obesity-induced adipose tissue inflammation in 3D-cultured human adipocytes and explant cultures. iScience. 2022 Jul 15;25(7):104602. doi: 10.1016/j.isci.2022.104602. eCollection 2022 Jul 15. PubMed PMID: 35789845; PubMed Central PMCID: PMC9249816.
Picarda E, Galbo PM Jr, Zong H, Rajan MR, Wallenius V, Zheng D, Börgeson E, Singh R, Pessin J, Zang X. The immune checkpoint B7-H3 (CD276) regulates adipocyte progenitor metabolism and obesity development. Sci Adv. 2022 Apr 29;8(17):eabm7012. doi: 10.1126/sciadv.abm7012. Epub 2022 Apr 27. PubMed PMID: 35476450; PubMed Central PMCID: PMC9045715.
Kraft JD, Blomgran R, Bergström I, Soták M, Clark M, Rani A, Rajan MR, Dalli J, Nyström S, Quiding-Järbrink M, Bromberg J, Skoog P, Börgeson E. Lipoxins modulate neutrophil oxidative burst, integrin expression and lymphatic transmigration differentially in human health and atherosclerosis. FASEB J. 2022 Mar;36(3):e22173. doi: 10.1096/fj.202101219RR. PubMed PMID: 35104001; PubMed Central PMCID: PMC9305188.
Soták M, Rajan MR, Clark M, Biörserud C, Wallenius V, Hagberg CE, Börgeson E. Healthy Subcutaneous and Omental Adipose Tissue Is Associated with High Expression of Extracellular Matrix Components. Int J Mol Sci. 2022 Jan 4;23(1). doi: 10.3390/ijms23010520. PubMed PMID: 35008946; PubMed Central PMCID: PMC8745535.
Stronczek C, Lange S, Bullard B, Wolniak S, Börgeson E, Mayans O, Fleming JR. The N2A region of titin has a unique structural configuration. J Gen Physiol. 2021 Jul 5;153(7). doi: 10.1085/jgp.202012766. PubMed PMID: 33836065; PubMed Central PMCID: PMC8042602.
Börgeson E, Sotak M, Kraft J, Bagunu G, Biörserud C, Lange S. Challenges in PhD education due to COVID-19 - disrupted supervision or business as usual: a cross-sectional survey of Swedish biomedical sciences graduate students. BMC Med Educ. 2021 May 22;21(1):294. doi: 10.1186/s12909-021-02727-3. PubMed PMID: 34022871; PubMed Central PMCID: PMC8140581.
Zhou T, Fleming JR, Lange S, Hessel AL, Bogomolovas J, Stronczek C, Grundei D, Ghassemian M, Biju A, Börgeson E, Bullard B, Linke WA, Chen J, Kovermann M, Mayans O. Molecular Characterisation of Titin N2A and Its Binding of CARP Reveals a Titin/Actin Cross-linking Mechanism. J Mol Biol. 2021 Apr 30;433(9):166901. doi: 10.1016/j.jmb.2021.166901. Epub 2021 Feb 27. PubMed PMID: 33647290; PubMed Central PMCID: PMC8052292.
Kraft JD, Blomgran R, Lundgaard I, Quiding-Järbrink M, Bromberg JS, Börgeson E. Specialized Pro-Resolving Mediators and the Lymphatic System. Int J Mol Sci. 2021 Mar 9;22(5). doi: 10.3390/ijms22052750. Review. PubMed PMID: 33803130; PubMed Central PMCID: PMC7963193.
Fleming JR, Rani A, Kraft J, Zenker S, Börgeson E, Lange S. Exploring Obscurin and SPEG Kinase Biology. J Clin Med. 2021 Mar 2;10(5). doi: 10.3390/jcm10050984. PubMed PMID: 33801198; PubMed Central PMCID: PMC7957886.
Rajan MR, Sotak M, Barrenäs F, Shen T, Borkowski K, Ashton NJ, Biörserud C, Lindahl TL, Ramström S, Schöll M, Lindahl P, Fiehn O, Newman JW, Perkins R, Wallenius V, Lange S, Börgeson E. Comparative analysis of obesity-related cardiometabolic and renal biomarkers in human plasma and serum. Sci Rep. 2019 Oct 28;9(1):15385. doi: 10.1038/s41598-019-51673-0. PubMed PMID: 31659186; PubMed Central PMCID: PMC6817872.
Hernandez-Carretero A, Weber N, La Frano MR, Ying W, Lantero Rodriguez J, Sears DD, Wallenius V, Börgeson E, Newman JW, Osborn O. Obesity-induced changes in lipid mediators persist after weight loss. Int J Obes (Lond). 2018 Apr;42(4):728-736. doi: 10.1038/ijo.2017.266. Epub 2017 Nov 1. PubMed PMID: 29089614; PubMed Central PMCID: PMC6055936.
Börgeson E, Wallenius V, Syed GH, Darshi M, Lantero Rodriguez J, Biörserud C, Ragnmark Ek M, Björklund P, Quiding-Järbrink M, Fändriks L, Godson C, Sharma K. AICAR ameliorates high-fat diet-associated pathophysiology in mouse and ex vivo models, independent of adiponectin. Diabetologia. 2017 Apr;60(4):729-739. doi: 10.1007/s00125-017-4211-9. Epub 2017 Feb 10. PubMed PMID: 28188334; PubMed Central PMCID: PMC6518112.
Zhong L, Ding Y, Bandyopadhyay G, Waaler J, Börgeson E, Smith S, Zhang M, Phillips SA, Mahooti S, Mahata SK, Shao J, Krauss S, Chi NW. The PARsylation activity of tankyrase in adipose tissue modulates systemic glucose metabolism in mice. Diabetologia. 2016 Mar;59(3):582-91. doi: 10.1007/s00125-015-3815-1. Epub 2015 Dec 2. PubMed PMID: 26631215.
Börgeson E, Johnson AM, Lee YS, Till A, Syed GH, Ali-Shah ST, Guiry PJ, Dalli J, Colas RA, Serhan CN, Sharma K, Godson C. Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney Disease. Cell Metab. 2015 Jul 7;22(1):125-37. doi: 10.1016/j.cmet.2015.05.003. Epub 2015 Jun 4. PubMed PMID: 26052006; PubMed Central PMCID: PMC4584026.
Börgeson E, Sharma K. Obesity, immunomodulation and chronic kidney disease. Curr Opin Pharmacol. 2013 Aug;13(4):618-24. doi: 10.1016/j.coph.2013.05.011. Epub 2013 Jun 7. Review. PubMed PMID: 23751262; PubMed Central PMCID: PMC4442271.
Corcoran JB, McCarthy S, Griffin B, Gaffney A, Bhreathnach U, Börgeson E, Hickey FB, Docherty NG, Higgins DF, Furlong F, Martin F, Godson C, Murphy M. IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responses. Biochim Biophys Acta. 2013 Aug;1833(8):1969-78. doi: 10.1016/j.bbamcr.2013.03.027. Epub 2013 Apr 6. PubMed PMID: 23567938.
Corcoran JB, McCarthy S, Griffin B, Gaffney A, Bhreathnach U, Börgeson E, Hickey FB, Docherty NG, Higgins DF, Furlong F, Martin F, Godson C, Murphy M. IHG-1 must be localised to mitochondria to decrease Smad7 expression and amplify TGF-β1-induced fibrotic responses. Biochim Biophys Acta. 2013 Aug;1833(8):1969-78. doi: 10.1016/j.bbamcr.2013.03.027. Epub 2013 Apr 6. PubMed PMID: 23567938.
Börgeson E, Godson C. Resolution of inflammation: therapeutic potential of pro-resolving lipids in type 2 diabetes mellitus and associated renal complications. Front Immunol. 2012;3:318. doi: 10.3389/fimmu.2012.00318. eCollection 2012. PubMed PMID: 23087692; PubMed Central PMCID: PMC3474937.
Börgeson E, McGillicuddy FC, Harford KA, Corrigan N, Higgins DF, Maderna P, Roche HM, Godson C. Lipoxin A4 attenuates adipose inflammation. FASEB J. 2012 Oct;26(10):4287-94. doi: 10.1096/fj.12-208249. Epub 2012 Jun 14. PubMed PMID: 22700871.
Börgeson E, Docherty NG, Murphy M, Rodgers K, Ryan A, O'Sullivan TP, Guiry PJ, Goldschmeding R, Higgins DF, Godson C. Lipoxin A₄ and benzo-lipoxin A₄ attenuate experimental renal fibrosis. FASEB J. 2011 Sep;25(9):2967-79. doi: 10.1096/fj.11-185017. Epub 2011 May 31. PubMed PMID: 21628447.
Börgeson E, Lönn J, Bergström I, Brodin VP, Ramström S, Nayeri F, Särndahl E, Bengtsson T. Lipoxin A₄ inhibits porphyromonas gingivalis-induced aggregation and reactive oxygen species production by modulating neutrophil-platelet interaction and CD11b expression. Infect Immun. 2011 Apr;79(4):1489-97. doi: 10.1128/IAI.00777-10. Epub 2011 Jan 24. PubMed PMID: 21263017; PubMed Central PMCID: PMC3067532.
Börgeson E, Godson C. Molecular circuits of resolution in renal disease. ScientificWorldJournal. 2010 Jul 7;10:1370-85. doi: 10.1100/tsw.2010.120. Review. PubMed PMID: 20623097; PubMed Central PMCID: PMC5763933.